Matches in Wikidata for { <http://www.wikidata.org/entity/Q64355408> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q64355408 description "2014 թվականի օգոստոսի 10-ին հրատարակված գիտական հոդված" @default.
- Q64355408 description "article scientifique publié en 2014" @default.
- Q64355408 description "artículu científicu espublizáu n'agostu de 2014" @default.
- Q64355408 description "im August 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64355408 description "scientific article published on 10 August 2014" @default.
- Q64355408 description "wetenschappelijk artikel" @default.
- Q64355408 description "наукова стаття, опублікована у вересні 2014" @default.
- Q64355408 name "Combining incretin-based drugs and RAAS inhibitors: more cons than pros?" @default.
- Q64355408 name "Combining incretin-based drugs and RAAS inhibitors: more cons than pros?" @default.
- Q64355408 type Item @default.
- Q64355408 label "Combining incretin-based drugs and RAAS inhibitors: more cons than pros?" @default.
- Q64355408 label "Combining incretin-based drugs and RAAS inhibitors: more cons than pros?" @default.
- Q64355408 prefLabel "Combining incretin-based drugs and RAAS inhibitors: more cons than pros?" @default.
- Q64355408 prefLabel "Combining incretin-based drugs and RAAS inhibitors: more cons than pros?" @default.
- Q64355408 P1433 Q64355408-9B0850E6-B2E1-4A04-915A-2772C25915F2 @default.
- Q64355408 P1476 Q64355408-72F8A205-85F8-4910-B3F2-CBFB37EACE16 @default.
- Q64355408 P2093 Q64355408-3F2F6BF8-1E98-4A5A-BD0F-F37D34E76C13 @default.
- Q64355408 P2093 Q64355408-B871A47C-77B8-4960-8C85-022DAB8680CB @default.
- Q64355408 P2860 Q64355408-027A216B-0C88-4F8A-93F6-4F89B5C01F31 @default.
- Q64355408 P2860 Q64355408-25AE3DA5-2559-4BA8-96FB-2B50C2AA91DA @default.
- Q64355408 P2860 Q64355408-5A2C03EB-BE3A-44E2-8799-114B46B40C81 @default.
- Q64355408 P2860 Q64355408-76E1B112-012C-4AB3-BB92-365DE52E4071 @default.
- Q64355408 P2860 Q64355408-A2DAD5ED-A4BF-4E3D-B6BB-84BF58891E3F @default.
- Q64355408 P2860 Q64355408-AF937A9B-255A-4DBA-8093-43C88FDD63D9 @default.
- Q64355408 P2860 Q64355408-CF088CB7-7662-4197-8233-698B19717DB5 @default.
- Q64355408 P304 Q64355408-5A03A1D7-20A1-4EAC-A1A0-E15E31C1FB09 @default.
- Q64355408 P31 Q64355408-CDF51768-83D1-482A-9D87-E98AADEC1873 @default.
- Q64355408 P356 Q64355408-46B7778B-14E2-4B9D-9E6A-4B61F101D0CF @default.
- Q64355408 P433 Q64355408-022A0821-2D8C-4A25-9B8E-47F92C29E1E2 @default.
- Q64355408 P478 Q64355408-47DA7370-686F-485C-BAEF-9413F3FE5ABD @default.
- Q64355408 P50 Q64355408-39B9A1B9-D46F-4294-A75E-F866F0D3A46F @default.
- Q64355408 P50 Q64355408-745C9A33-0D8F-4EA4-A60A-E1B0B43A8A0D @default.
- Q64355408 P50 Q64355408-B77735F0-9943-40C3-9EA5-C3BAF64E9374 @default.
- Q64355408 P577 Q64355408-033021BE-F0FD-47E6-94EF-E5EB7708E5DB @default.
- Q64355408 P698 Q64355408-8D367EE9-3743-45CF-8773-E630117C5FBD @default.
- Q64355408 P356 S2213-8587(14)70167-6 @default.
- Q64355408 P698 25127482 @default.
- Q64355408 P1433 Q27725107 @default.
- Q64355408 P1476 "Combining incretin-based drugs and RAAS inhibitors: more cons than pros?" @default.
- Q64355408 P2093 "Daniël H van Raalte" @default.
- Q64355408 P2093 "Lennart Tonneijck" @default.
- Q64355408 P2860 Q35833586 @default.
- Q64355408 P2860 Q37699068 @default.
- Q64355408 P2860 Q38174491 @default.
- Q64355408 P2860 Q39030156 @default.
- Q64355408 P2860 Q42949053 @default.
- Q64355408 P2860 Q44924385 @default.
- Q64355408 P2860 Q45730273 @default.
- Q64355408 P304 "684-685" @default.
- Q64355408 P31 Q13442814 @default.
- Q64355408 P356 "10.1016/S2213-8587(14)70167-6" @default.
- Q64355408 P433 "9" @default.
- Q64355408 P478 "2" @default.
- Q64355408 P50 Q108578052 @default.
- Q64355408 P50 Q42876438 @default.
- Q64355408 P50 Q64358414 @default.
- Q64355408 P577 "2014-08-10T00:00:00Z" @default.
- Q64355408 P698 "25127482" @default.